• 1. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

Introduction to 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt (CAS No: 60277-40-9)

4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt, identified by the Chemical Abstracts Service Number (CAS No) 60277-40-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, characterized by its biphenyl core structure modified with an aminomethyl group at the 4' position and a hydrochloric acid salt form, exhibits unique chemical and pharmacological properties that make it a subject of interest for various applications.

The molecular structure of 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt consists of two benzene rings connected by a single bond, with one ring substituted by an hydroxyl group at the 4-position and an aminomethyl group at the 4'-position. The presence of these functional groups imparts distinct reactivity and binding capabilities, making it a valuable intermediate in the synthesis of more complex molecules. The hydrochloric acid salt form enhances the solubility and stability of the compound, facilitating its use in solution-based reactions and formulations.

In recent years, there has been growing interest in biphenyl derivatives due to their potential applications in drug development. The aminomethyl group in 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt serves as a versatile handle for further functionalization, allowing chemists to explore its utility in creating novel pharmacophores. This flexibility has made it a candidate for investigating its role in the design of new therapeutic agents targeting various biological pathways.

One of the most compelling aspects of 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt is its potential in medicinal chemistry. Researchers have been exploring its interactions with biological targets, particularly enzymes and receptors, to identify possible therapeutic effects. Preliminary studies suggest that this compound may exhibit properties relevant to neurological disorders, inflammation, and cancer research. The hydroxyl and amine functionalities provide multiple sites for hydrogen bonding and other non-covalent interactions, which are crucial for drug-receptor binding affinity.

The synthesis of 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt involves multi-step organic reactions that require precise control over reaction conditions. The introduction of the aminomethyl group at the 4'-position of the biphenyl core is typically achieved through nucleophilic substitution or reduction reactions. The subsequent formation of the hydrochloric acid salt ensures improved handling properties and compatibility with various pharmaceutical formulations. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions, have been employed to enhance yield and purity.

From an industrial perspective, the production of 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt on a larger scale presents both challenges and opportunities. Optimizing synthetic routes for cost-effectiveness and scalability is essential for its commercial viability. Additionally, stringent quality control measures must be implemented to ensure consistency in batch-to-batch performance, which is critical for pharmaceutical applications. Collaborative efforts between academic researchers and industry professionals are vital in advancing the development and application of this compound.

The pharmacological profile of 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt is still under active investigation, but early findings are promising. In vitro studies have demonstrated interactions with specific enzymes that play roles in metabolic pathways associated with diseases such as diabetes and cardiovascular disorders. Furthermore, its structural features suggest potential as an antioxidant agent due to the presence of both hydroxyl and amine groups capable of scavenging reactive oxygen species.

Future research directions may focus on developing derivatives of 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt with enhanced pharmacological activity or improved pharmacokinetic properties. Computational modeling techniques can aid in predicting molecular interactions and optimizing drug-like characteristics before experimental validation. Such interdisciplinary approaches are key to unlocking the full therapeutic potential of this compound.

The regulatory landscape for compounds like 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt is another critical consideration. Compliance with Good Manufacturing Practices (GMP) and other regulatory guidelines ensures that pharmaceutical products derived from this intermediate meet safety and efficacy standards. As research progresses, collaboration with regulatory agencies will be essential to streamline approvals for new drug candidates incorporating this compound.

In conclusion, 4'-(Aminomethyl)-biphenyl-4-ol Hydrochloric Acid Salt (CAS No: 60277-40-9) represents a promising entity in pharmaceutical chemistry with diverse applications ranging from intermediate synthesis to drug development. Its unique structural features offer opportunities for designing novel therapeutics targeting various diseases. Continued exploration into its pharmacological properties, coupled with advancements in synthetic methodologies, will likely expand its role in medicinal chemistry and industrial applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)